INNOGENE

INNOGENE (Korean: 이노진) is a South Korean anti-aging bio company and cosmeceutical specialist focused on hair loss and problem-skin/rejuvenation. Founded on September 7, 2005, the company provides total solutions spanning home care, scalp-care devices, health functional foods, and pharmaceuticals to domestic hospitals and clinics, and exports to the United States, China, Singapore, Hong Kong, and Malaysia. It listed on the KOSDAQ market on February 20, 2023. Its main product lines are hair-loss products and skin-beauty products; in 2025, hair-loss products accounted for approximately 83% of total revenue of 8.2 billion won, while skin-beauty products accounted for about 17%. The company continues to expand its business scope, including entering the bio-technology-based care food market through a May 2026 agreement with Darmedalum, a specialist in functional ingredient injection technology using natural extracts, and signing a July 2026 MOU with Humic, a non-clinical CRO, for joint R&D in anti-aging bio and healthcare.

INNOGENE was established on September 7, 2005, in South Korea. The company built its business around anti-aging bio solutions, with a particular focus on hair loss and problem-skin/rejuvenation. It developed a portfolio that includes home care products, scalp-care devices, health functional foods, and pharmaceuticals, and it supplies these total solutions to hospitals and clinics in South Korea. The company also expanded internationally, exporting to the United States, China, Singapore, Hong Kong, and Malaysia. On February 20, 2023, INNOGENE listed on the KOSDAQ market. In 2025, the company reported revenue of 8.2 billion won, with hair-loss products contributing approximately 83% and skin-beauty products about 17%. In May 2026, INNOGENE signed a business agreement with Darmedalum, a company specializing in functional ingredient injection technology using natural extracts, to enter the bio-technology-based care food market. In July 2026, it signed an MOU with Humic, a non-clinical CRO, for joint R&D in the anti-aging bio and healthcare sectors, continuing to expand its business areas.

• INNOGENE founded

• Listed on KOSDAQ

• Signed MOU with Darmedalum to enter bio-based care food market

• Signed MOU with Humic for joint R&D in anti-aging bio and healthcare

Total solution provider for hair loss and problem-skin/rejuvenation, from home care to medical devices, health foods, and pharmaceuticals.

• Hair loss product line

  Products targeting hair loss, accounting for approximately 83% of 2025 revenue.

• Skin beauty product line

  Skin care and beauty products, accounting for approximately 17% of 2025 revenue.

1. 1이노진 - 위키백과ko.wikipedia.org
2. 2Wikidata Q131188171wikidata.org